09:00 AM
Approx. 50 minutesRecent Advances in Lung Cancer Screening, Risk Assessment, Imaging, and Early Diagnosis: What is Ready for Prime Time?
Add to calendar
02:00 PM
Approx. 50 minutesCustomized Chemotherapy and Targeted Therapy in Melanoma Management
Add to calendar
03:00 PM
Approx. 50 minutesUse of Chemoimmunotherapy in Patients with Advanced Melanoma
Add to calendar
09:00 AM
Approx. 50 minutesTargeted Therapy and Chemotherapy in Advanced Melanoma
Paul B. Chapman, MD
Medical Oncologist
10:00 AM
Approx. 50 minutesQuestions in the Surgical Management of Melanoma
11:00 AM
Approx. 50 minutesImmunotherapy in Patients with High Risk and Advanced Melanoma
12:00 PM
Approx. 50 minutesFuture Directions in Melanoma Therapy - Round Table Discussion
Evan J. Lipson, M.D.
Instructor, Medical Oncology
Howard L. Kaufman, MD
Director
William Sharfman, MD
Associate Professor of Oncology and Dermatology
01:00 PM
Approx. 50 minutesAre We Ready to Move to Annual Screening for Lung Cancer in High Risk Patients?
02:00 PM
Approx. 50 minutesRecent developments in targeted therapy for NSCLC
03:00 PM
Approx. 50 minutesApplication of Advancements in Biomarker Identification to Clinical Practice in Patients with NSCLC. Is it Ready for Primetime?
David S. Ettinger, MD
The Alex Grass Professor of Oncology
Peter Bela Illei, MD
Assistant Professor of Pathology
04:00 PM
Approx. 50 minutesOptimizing Therapy Choices in Patients With SCLC
David S. Ettinger, MD
The Alex Grass Professor of Oncology
Jeffrey Crawford, MD
Chief, Division of Medical Oncology
12:30 PM
Approx. 30 minutesThe State of Cancer Care in the Coming Decade
Featuring William Nelson, MD from Johns Hopkins University School of Medicine.
William Nelson, MD
Professor of Oncology & Director
01:00 PM
Approx. 50 minutesPerspectives in Multiple Myeloma: Transplantation, Maintenance Therapy and Optimal Initial Treatment Regimen
Featuring Vincent Rajkumar, MD from the Mayo Clinic and Nilanjan Ghosh, MBBS, PhD from the Sidney Kimmel Comprehensive Cancer Center. Moderated by Carol Ann Huff, MD from Johns Hopkins University School of Medicine.
Carol Ann Huff, M.D.
Director, Myeloma Program
Nilanjan Ghosh, MBBS, PhD
Assistant Professor of Oncology
S. Vincent Rajkumar, MD
Professor of Medicine
02:00 PM
Approx. 50 minutesCLL-- Treatment of High-Risk Disease in a Young Patient
Featuring Jack Goldberg from the University of Pennsylvania and Nicole Lamanna from MSKCC, New York. Moderated by Douglas Gladstone, MD from Johns Hopkins University School of Medicine.
Douglas Gladstone, MD
Associate Professor of Oncology
Jack Goldberg, MD
Chief, Division of Hematology and Medical Oncology
Nicole Lamanna, MD
Medical Oncologist
04:00 PM
Approx. 50 minutesNew Agents in NHL: Where Do They Fit in the Treatment Paradigm?
Featuring Ron Gartenhaus from the University of Maryland and Myron Czuczman from the Roswell Park Cancer Institute. Moderated by Aaron Rapoport, MD, from the University of Maryland.
05:00 PM
Approx. 50 minutesDebate: ALL in Adolescents and Young Adults – Is It a Different Disease?
Featuring Wendy Stock, MD from the University of Chicago Comprehensive Cancer Center and Stephen, Hunger, MD from The Children’s Hospital, Denver. Moderated by Pat Brown, MD from Johns Hopkins University School of Medicine.
Patrick Brown, MD
Assistant Professor of Oncology
Stephen Hunger, MD
Associate Director
Wendy Stock, MD
Professor of Medicine
03:00 PM
Approx. 50 minutesUpdate on PNH: The Consequences of Chronic Hemolysis
Featuring Ilene C. Weitz, MD from the University of Southern California.
Ilene C. Weitz, MD
Associate Professor of Clinical Medicine
12:00 PM
Approx. 60 minutesON DEMAND: Detection and Diagnosis of Paroxysmal Nocturnal Hemoglobinuria (PNH)
Featuring Michael J. Borowitz, MD, PhD from Johns Hopkins University School of Medicine.
Michael J. Borowitz, M.D., Ph.D.
Director, Division of Hematologic Pathology
01:00 PM
Approx. 60 minutesON DEMAND: Pathophysiology of Paroxysmal Nocturnal Hemoglobinuria (PNH)
Featuring Robert A. Brodsky, MD from Johns Hopkins University School of Medicine.
Robert A. Brodsky, M.D.
Director, Division of Hematology